-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Public Notice on Public Participation in the Emergency Response Plan for Sudden Environmental Incidents at the Phase I Project of Hebei Guangxiang Pharmaceutical Co., Ltd.
Category:
发布时间：2019-09-30
【概要描述】
In accordance with the Requirements for Public Participation in Environmental Impact Assessment, promulgated by the Ministry of Ecology and Environment on April 16, 2018, and in order to promote and standardize public participation in emergency response plans and ensure that nearby residents and organizations have access to information on such plans, the relevant contents and outcomes of the Comprehensive Emergency Response Plan for Sudden Environmental Incidents for Phase I of Hebei Guangxiang Pharmaceutical Co., Ltd. are hereby made public as follows.
In accordance with the Requirements for Public Participation in Environmental Impact Assessment, promulgated by the Ministry of Ecology and Environment on April 16, 2018, and in order to promote and standardize public participation in emergency response plans and ensure that nearby residents and organizations have access to information on such plans, the relevant contents and outcomes of the Comprehensive Emergency Response Plan for Sudden Environmental Incidents for Phase I of Hebei Guangxiang Pharmaceutical Co., Ltd. are hereby made public as follows:
I. Overview of the Emergency Plan
Plan Name: Comprehensive Emergency Response Plan for Sudden Environmental Incidents in Phase I of Hebei Guangxiang Pharmaceutical Co., Ltd.
Prepared by: Hebei Guangxiang Pharmaceutical Co., Ltd.
Plan Content: The plan includes the Preparation Instructions for the Environmental Emergency Plan, the text of the Environmental Emergency Plan, the Environmental Risk Assessment Report, and the Environmental Emergency Resources Survey Report. Specifically, the text of the Environmental Emergency Plan comprises the Comprehensive Emergency Plan for Sudden Environmental Incidents, the Special Emergency Plan for Atmospheric Environmental Incidents, the Special Emergency Plan for Water Environmental Incidents, and the On-site Response Plan for Sudden Environmental Incidents.
II. Methods for Obtaining the Draft for Comments
The full electronic version of the draft “Comprehensive Emergency Response Plan for Sudden Environmental Incidents—Phase I Project of Hebei Guangxiang Pharmaceutical Co., Ltd.” is available for online download via the following link: https://pan.baidu.com/s/10M15IHXdEQtjR3csGWmtvw; extraction code: 1cy8. A hard copy of the report can be obtained from the office of Hebei Guangxiang Pharmaceutical Co., Ltd., contact person: Jiao Xuefan.
III. Public Consultation Scope of the Draft
The scope of this public consultation encompasses Liuguanzhuang Village, Xuzhuangzi Village, Mazhuangzi Village, Xuezhuangzi Village, Xinzhuangzi Village, Team 19 of the Sixth Sub-farm, Xingzhuangke Village, Team 9 of the Third Sub-farm, the Fifth Sub-farm, the Coastal Economic Zone, Daguozhuang Village, and all enterprises within the assessment area.
IV. Link to Public Comments
The online download link for the public opinion form is https://pan.baidu.com/s/14ooJMNjrTT897bbDZBZEFA, with extraction code: hru1.
V. Methods and Channels for Public Submission of Comments
Within the scope of this assessment, members of the public may download the Public Comments Form or obtain it from the office of Hebei Guangxiang Pharmaceutical Co., Ltd. They are encouraged to complete the form with suggestions and comments related to this emergency response plan and associated emergency measures, and submit it to Jiao Xuefan at the office of Hebei Guangxiang Pharmaceutical Co., Ltd. for safekeeping and statistical compilation.
VI. Name and Contact Information of the Contingency Plan Unit
Unit Name: Hebei Guangxiang Pharmaceutical Co., Ltd.
Address: Biopharmaceutical Industrial Park, Lingang Economic and Technological Development Zone, Bohai New Area, Cangzhou
Contact: Jiao Xuefan Phone: 13230711037
Email: jiaoxuefan@sjzsiyao.com
Hebei Guangxiang Pharmaceutical Co., Ltd.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091